CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $5.78B, above the global median of $1.15B
- FinancialsHigh structural barrier to entry
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.78BUSDvs all stocks (USD)
Trailing P/E
75.84xRevenue (TTM)
840.85MUSDvs all stocks (USD)
Profit Margin
9.59%Beta
0.0870xvs all stocks
52-Week Change
93.66%vs all stocks
Market Capitalization
5.78BUSDvs all stocks (USD)
Enterprise Value
5.34BUSDvs all stocks (USD)
Trailing P/E
75.84xForward P/E
46.42xPEG Ratio
2.02xPrice to Sales (TTM)
6.97xPrice to Book (MRQ)
8.95xEnterprise to Revenue
6.35xEnterprise to EBITDA
52.34xGross Margin
54.17%Profit Margin
9.59%Operating Margin
11.16%Return on Assets (TTM)
8.05%Return on Equity (TTM)
14.04%Revenue (TTM)
840.85MUSDvs all stocks (USD)
Revenue per Share (TTM)
11.03USDUpdated Sep 27, 2026Quarterly Revenue Growth
55.40%Gross Profit (TTM)
458.30MUSDvs all stocks (USD)
EBITDA (TTM)
102.04MUSDvs all stocks (USD)
Net Income (TTM)
80.66MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
42.60%Operating Cash Flow (TTM)
184.96MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
126.14MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
677.56MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
307.22MUSDFY2025 · Dec 31, 2025Gross Profit
370.35MUSDFY2025 · Dec 31, 2025Operating Income
77.22MUSDvs all stocks (USD)
Pre-tax Income
88.87MUSDFY2025 · Dec 31, 2025Income Tax Expense
29.86MUSDFY2025 · Dec 31, 2025Net Income
59.01MUSDFY2025 · Dec 31, 2025EBIT
77.22MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
78.78MUSDFY2025 · Dec 31, 2025Research & Development
96.85MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
196.27MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
59.01MUSDFY2025 · Dec 31, 2025Operating Cash Flow
124.00MUSDFY2025 · Dec 31, 2025Free Cash Flow
122.44MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
165.60MUSDFY2025 · Dec 31, 2025Income Tax Paid
3.01MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
59.01MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.55MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
13.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
37.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
3.67MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
26.13MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
142.00KUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-16.50MUSDFY2025 · Dec 31, 2025Capital Expenditures
-1.57MUSDFY2025 · Dec 31, 2025Purchase of Investments
-386.92MUSDFY2025 · Dec 31, 2025Sale of Investments
199.49MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-188.99MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-7.73MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-7.73MUSDFY2025 · Dec 31, 2025Shares Outstanding
77.98MSharesUpdated Sep 27, 2026Float Shares
39.86MSharesUpdated Sep 27, 2026Shares Short
3.88MSharesUpdated Sep 27, 2026Short Ratio
7.89daysvs all stocks
Short % of Shares Outstanding
9.70%vs all stocks
% Held by Insiders
3.51%vs all stocks
% Held by Institutions
100.91%vs all stocks
Total Cash (MRQ)
525.93MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
6.74USDUpdated Sep 27, 2026Total Debt (MRQ)
8.90MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0136xCurrent Ratio (MRQ)
3.90xBook Value per Share (MRQ)
8.39USDUpdated Sep 27, 2026Total Assets
763.63MUSDvs all stocks (USD)
Total Current Assets
527.18MUSDFY2025 · Dec 31, 2025Total Liabilities
196.03MUSDFY2025 · Dec 31, 2025Total Non-current Assets
236.46MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
56.84MUSDFY2025 · Dec 31, 2025Total Current Liabilities
139.18MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
165.60MUSDFY2025 · Dec 31, 2025Other Short-term Investments
248.48MUSDFY2025 · Dec 31, 2025Accounts Receivable
15.59MUSDFY2025 · Dec 31, 2025Inventory
54.90MUSDFY2025 · Dec 31, 2025Accounts Payable
2.03MUSDFY2025 · Dec 31, 2025Short-term Debt
2.99MUSDFY2025 · Dec 31, 2025Other Current Liabilities
22.13MUSDFY2025 · Dec 31, 2025Long-term Debt
6.51MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
18.52MUSDFY2025 · Dec 31, 2025Common Stock (Book)
21.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-462.14MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
567.61MUSDvs all stocks (USD)
52-Week Low
35.20USDUpdated Sep 27, 202652-Week High
82.94USDUpdated Sep 27, 202652-Week Change
93.66%vs all stocks
Beta
0.0870xvs all stocks
50-Day MA
75.76USDUpdated Sep 27, 2026200-Day MA
55.36USDUpdated Sep 27, 2026Avg 10-Day Volume
567.58KSharesUpdated Sep 27, 2026Avg 30-Day Volume
508.57KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
0.9900USDUpdated Sep 27, 2026Other Income / Expense
11.65MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
High structural barrier to entryNotable
Barrier to Entry: 3.19
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $5.78B, above the global median of $1.15BNotable
Market cap (USD): 5,776,506,395Global Median: 1,150,342,212.262
Revenue is $840.85M, above the global median of $559.35MNotable
Revenue (USD): 840,848,000Global Median: 559,350,010.583
Levered free cash flow is $126.14M, above the global median of $18.98MNotable
Levered free cash flow (USD): 126,144,248Global Median: 18,979,762.15
Companies that share the same coordination system — how they create, deliver, or capture value.
Mirum Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
APT Medical Inc.
Tier 1ProductionApproval-Gated PipelineRule
Scholar Rock Holding Corporation
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai Allist Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cogent Biosciences, Inc.
Tier 1ProductionApproval-Gated PipelineRule
CG Oncology, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Travere Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Oruka Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. A Shares
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Liquidia Corporation
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Strategic Minerals Plc
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Park Aerospace Corp
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Evolution AB (publ)
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities